---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-349334"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2026-08-13T20:31:25+00:00"
generated_at: "2026-08-13T20:33:57.274082+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics enters $50M equity purchase agreement with Lincoln Park Capital

## Summary
- Up to $50M common stock purchase commitment; initial $25M available, auto-increases to $50M.
- Commitment fee: 560,356 shares issued immediately; 350,223 additional after full funding of initial $25M.
- Company controls timing/amount; regular purchases up to 60,000 shares (max $500k per purchase) at market-based prices.
- Lincoln Park capped at 4.99% beneficial ownership; no short sales; company can terminate with 1 business day notice.
- Exchange cap 19.99% unless stockholder approval or average price >= $1.3854 per share.

## SEC filing metadata
- accession: 0001193125-26-349334
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2026-08-13T20:31:25+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312526349334/0001193125-26-349334-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312526349334/d290418d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-349334
- JSON: https://secwatch.observer/filing/0001193125-26-349334.json
- Plain text: https://secwatch.observer/filing/0001193125-26-349334.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.